• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

我们应该如何利用年龄来分配医疗保健资源?肾移植案例带来的启示。

How should we use age to ration health care? Lessons from the case of kidney transplantation.

机构信息

Renal Division, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

出版信息

J Am Geriatr Soc. 2010 Oct;58(10):1980-6. doi: 10.1111/j.1532-5415.2010.03031.x. Epub 2010 Sep 9.

DOI:10.1111/j.1532-5415.2010.03031.x
PMID:20831719
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4570233/
Abstract

Competing visions for health reform in the United States and renewed interest in health technology assessment (HTA) have led to fierce national debates about the appropriateness of rationing. Because of a limited supply of organs, kidney transplantation has always required rationing and overt discussion of the ethics that guide it, but the field of transplantation has also contended recently with internal calls for a new rationing system. The aim of the Life Years from Transplantation (LYFT) proposal is to allocate kidneys to patients who obtain the greatest survival benefit from transplantation, which would lengthen the lives of kidney transplant recipients but restrict the ability of older Americans to obtain a transplant. The debate around the LYFT proposal reveals the ethical and policy challenges of identifying which patients should receive a treatment based on the results of cost-effectiveness and other HTA studies. This article argues that attempts to use HTA for healthcare rationing are likely to disadvantage older patients. Guiding principles to help ensure that resources such as kidneys are justly allocated across the life span are proposed.

摘要

美国医疗改革的不同愿景以及对健康技术评估(HTA)的重新关注,引发了关于配给制是否合理的激烈全国性辩论。由于器官供应有限,肾移植一直需要配给制,并且需要公开讨论指导其配给的伦理问题,但移植领域最近也对新的配给制度提出了内部要求。《移植生命年》(LYFT)提案的目的是将肾脏分配给那些从移植中获得最大生存获益的患者,这将延长肾移植受者的寿命,但限制了美国老年人获得移植的能力。围绕 LYFT 提案的辩论揭示了在确定哪些患者应根据成本效益和其他 HTA 研究的结果接受治疗时,所面临的伦理和政策挑战。本文认为,试图将 HTA 用于医疗保健配给制可能会使老年患者处于不利地位。本文提出了一些指导原则,以帮助确保在整个生命周期内公平分配肾脏等资源。

相似文献

1
How should we use age to ration health care? Lessons from the case of kidney transplantation.我们应该如何利用年龄来分配医疗保健资源?肾移植案例带来的启示。
J Am Geriatr Soc. 2010 Oct;58(10):1980-6. doi: 10.1111/j.1532-5415.2010.03031.x. Epub 2010 Sep 9.
2
Directed donation: what is a transplant center to do?定向捐赠:移植中心该怎么做?
Nephrol Nurs J. 2005 Nov-Dec;32(6):701-2.
3
The debate over health care rationing: Déjà vu all over again?关于医疗保健资源分配的争论:似曾相识?
Inquiry. 2012 Summer;49(2):90-100. doi: 10.5034/inquiryjrnl_49.02.06.
4
Age-based rationing of health care.基于年龄的医疗保健配给。
Hawaii Med J. 1995 Apr;54(4):507-9.
5
Kidneys from deceased donors: maximizing the value of a scarce resource.来自已故捐赠者的肾脏:最大化稀缺资源的价值。
Am J Transplant. 2005 Jul;5(7):1725-30. doi: 10.1111/j.1600-6143.2005.00923.x.
6
Cost-effectiveness of repeat medical procedures: kidney transplantation as an example.重复医疗程序的成本效益:以肾移植为例。
Med Decis Making. 1997 Oct-Dec;17(4):363-72. doi: 10.1177/0272989X9701700401.
7
Health technology assessment (HTA): ethical aspects.卫生技术评估(HTA):伦理方面。
Med Health Care Philos. 2009 Nov;12(4):453-7. doi: 10.1007/s11019-009-9206-y. Epub 2009 Jun 9.
8
Role of Culture, Values, and Politics in the Implementation of Health Technology Assessment in India: A Commentary.文化、价值观和政治在印度实施卫生技术评估中的作用:评论。
Value Health. 2020 Jan;23(1):39-42. doi: 10.1016/j.jval.2019.10.002. Epub 2019 Dec 6.
9
The challenge of doing what is right in renal transplantation: balancing equity and utility.肾移植中做出正确决策的挑战:平衡公平与效用。
Nephron Clin Pract. 2009;111(1):c62-7; discussion c68. doi: 10.1159/000180121. Epub 2008 Dec 5.
10
The allocation of cadaveric kidneys.尸体肾的分配
N Engl J Med. 1999 Nov 4;341(19):1468-9. doi: 10.1056/NEJM199911043411911.

引用本文的文献

1
Old Age and Frailty in Deceased Organ Transplantation and Allocation-A Plea for Geriatric Assessment and Prehabilitation.老年和虚弱与器官移植和分配-老年评估和预康复的呼吁。
Transpl Int. 2023 Jul 5;36:11296. doi: 10.3389/ti.2023.11296. eCollection 2023.
2
Life-Years & Rationing in the Covid-19 Pandemic: A Critical Analysis.新冠疫情下的寿命年数与资源分配:批判性分析。
Hastings Cent Rep. 2021 Sep;51(5):18-29. doi: 10.1002/hast.1283.
3
Rationing With Respect to Age During a Pandemic: A Comparative Analysis of State Pandemic Preparedness Plans.大流行期间按年龄分配资源:国家大流行防范计划的比较分析。
Chest. 2022 Feb;161(2):504-513. doi: 10.1016/j.chest.2021.08.070. Epub 2021 Sep 8.
4
Ethics Consultation for Adult Solid Organ Transplantation Candidates and Recipients: A Single Centre Experience.成人实体器官移植候选人和受者的伦理咨询:单中心经验。
J Bioeth Inq. 2021 Jul;18(2):291-303. doi: 10.1007/s11673-021-10092-5. Epub 2021 Feb 26.
5
Simulating the new kidney allocation policy in the United States: modest gains and many unknowns.模拟美国新的肾脏分配政策:收益有限且未知因素众多。
J Am Soc Nephrol. 2014 Aug;25(8):1617-9. doi: 10.1681/ASN.2014030235. Epub 2014 May 15.
6
Bioethics of organ transplantation.器官移植的生命伦理学。
Cold Spring Harb Perspect Med. 2014 Mar 1;4(3):a015685. doi: 10.1101/cshperspect.a015685.
7
The redefinition of aging in American surgery.美国外科手术中对衰老的重新定义。
Milbank Q. 2013 Jun;91(2):288-315. doi: 10.1111/milq.12014.
8
One and done? Equality of opportunity and repeated access to scarce, indivisible medical resources.一劳永逸?机会均等与稀缺、不可分割的医疗资源的重复获取
BMC Med Ethics. 2012 May 24;13:11. doi: 10.1186/1472-6939-13-11.
9
Aging and transplantation - a topic for biomedicine or bioethics?衰老与移植——生物医学还是生命伦理学的议题?
Aging Dis. 2011 Apr;2(2):181-5. Epub 2011 Feb 22.

本文引用的文献

1
Kidney transplantation in the elderly.老年患者的肾移植。
Semin Nephrol. 2009 Nov;29(6):621-35. doi: 10.1016/j.semnephrol.2009.07.011.
2
Physical function in older candidates for renal transplantation: an impaired population.老年肾移植候选者的身体功能:一个功能受损的群体。
Clin J Am Soc Nephrol. 2009 Mar;4(3):588-94. doi: 10.2215/CJN.03860808. Epub 2009 Mar 4.
3
The Obama administration's options for health care cost control: hope versus reality.奥巴马政府控制医疗成本的选择:希望与现实
Ann Intern Med. 2009 Apr 7;150(7):485-9. doi: 10.7326/0003-4819-150-7-200904070-00114. Epub 2009 Mar 2.
4
Effect of comorbidity adjustment on CMS criteria for kidney transplant center performance.合并症调整对医疗保险和医疗补助服务中心(CMS)肾脏移植中心绩效标准的影响。
Am J Transplant. 2009 Mar;9(3):506-16. doi: 10.1111/j.1600-6143.2008.02527.x. Epub 2009 Feb 3.
5
Principles for allocation of scarce medical interventions.稀缺医疗干预措施的分配原则。
Lancet. 2009 Jan 31;373(9661):423-31. doi: 10.1016/S0140-6736(09)60137-9.
6
Predictive ability of pretransplant comorbidities to predict long-term graft loss and death.移植前合并症对预测长期移植物丢失和死亡的预测能力。
Am J Transplant. 2009 Mar;9(3):494-505. doi: 10.1111/j.1600-6143.2008.02486.x. Epub 2008 Dec 15.
7
Information on cost-effectiveness: an essential product of a national comparative effectiveness program.成本效益信息:国家比较效果计划的一项重要成果。
Ann Intern Med. 2008 Jun 17;148(12):956-61. doi: 10.7326/0003-4819-148-12-200806170-00222. Epub 2008 May 15.
8
Calculating life years from transplant (LYFT): methods for kidney and kidney-pancreas candidates.计算移植后的生命年数(LYFT):肾和肾胰联合移植候选者的方法
Am J Transplant. 2008 Apr;8(4 Pt 2):997-1011. doi: 10.1111/j.1600-6143.2008.02177.x.
9
The development of new allocation policy for deceased donor kidneys.deceased捐赠肾脏新分配政策的制定 。 需要注意的是,这里“deceased donor”准确来说是“已故捐赠者” ,整句话准确的译文是:已故捐赠者肾脏新分配政策的制定 。
Curr Opin Nephrol Hypertens. 2007 Nov;16(6):512-5. doi: 10.1097/MNH.0b013e3282f08638.
10
Renal transplantation in elderly patients older than 70 years of age: results from the Scientific Registry of Transplant Recipients.70岁以上老年患者的肾移植:来自移植受者科学登记处的结果。
Transplantation. 2007 Apr 27;83(8):1069-74. doi: 10.1097/01.tp.0000259621.56861.31.